The landscape of dementia diagnosis has progressed substantially with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based exams which will detect Alzheimer's pathology decades before signs emerge. Even though these technological advancements characterize remarkable development in comprehending neuro